title: Disabling Parkinsonism following brief exposure to lithium carbonate in amyotrophic lateral sclerosis.
authors.forename: L
authors.initials: L
authors.lastname: Mazzini
authors.forename: G D
authors.initials: GD
authors.lastname: Oggioni
authors.forename: N
authors.initials: N
authors.lastname: Nasuelli
authors.forename: S
authors.initials: S
authors.lastname: Servo
authors.forename: L
authors.initials: L
authors.lastname: Testa
authors.forename: F
authors.initials: F
authors.lastname: Monaco
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000503:physiopathology; D020734:Parkinsonian Disorders / Q000139:chemically induced* / Q000503:physiopathology
chemical_list: D004791:Enzyme Inhibitors; D016651:Lithium Carbonate